A nurse is preparing to administer medications to a client who has type 1 diabetes mellitus.The client takes lispro insulin and has a new prescription for pramlintide.Which of the following actions should the nurse take?

Choice A rationalePramlintide does not cause significant weight gain. It is used to control blood glucose levels and might promote slight weight loss, not weight gain, hence irrelevant monitoring.Choice B rationaleMonitor for hypoglycemia for 3 hours post pramlintide administration, as it delays gastric emptying and reduces glucagon secretion, risking prolonged low blood sugar levels.Choice C rationalePramlintide is injected subcutaneously in the abdomen or thigh, not the upper arm. Proper site selection ensures optimal absorption and efficacy in controlling blood glucose.Choice D rationalePramlintide is administered immediately before meals to slow gastric emptying and reduce postprandial glucose spikes. It’s not given 30 minutes prior but just before eating for efficacy. .NGN Questions